Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosisWilliam Damsky, Brett King, Katelyn Singh et al.|Nature Communications|2022Cited by 128
Patient perspectives on the lived experience of granuloma annulareAbigale Clark, William Damsky, Michael J. Murphy et al.|British Journal of Dermatology|2022Cited by 6